AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 75(1), 2006, pp. 152-154
Copyright © 2006 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by COHUET, S.
Right arrow Articles by GUTHMANN, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by COHUET, S.
Right arrow Articles by GUTHMANN, J.-P.
Related Collections
Right arrow Drug-Resistance
Right arrow Malaria

SHORT REPORT


MOLECULAR MARKERS ASSOCIATED WITH PLASMODIUM FALCIPARUM RESISTANCE TO SULFADOXINE-PYRIMETHAMINE IN THE DEMOCRATIC REPUBLIC OF CONGO

SANDRA COHUET, MARYLINE BONNET, MICHEL VAN HERP, CHANTAL VAN OVERMEIR, UMBERTO D’ALESSANDRO, AND JEAN-PAUL GUTHMANN*
Epicentre, Paris, France; Médecins Sans Frontières, Brussels, Belgium; Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium

 

ABSTRACT

Sulfadoxine-pyrimethamine (SP) is the first line antimalarial treatment in the Democratic Republic of Congo. Using polymerase chain reaction, we assessed the prevalence of mutations in the dihydrofolate reductase (dhfr) (codons 108, 51, 59) and dihydropteroate synthase (dhps) (codons 437, 540) genes of Plasmodium falciparum, which have been associated with resistance to pyrimethamine and sulfadoxine, respectively. Four hundred seventy-four patients were sampled in Kilwa (N = 138), Kisangani (N = 112), Boende (N = 106), and Basankusu (N = 118). The proportion of triple mutations dhfr varied between sites but was always > 50%. The proportion of dhps double mutations was < 20%, with some sites as low as 0.9%. A quintuple mutation was present in 12.8% (16/125) samples in Kilwa; 11.9% (13/109) in Kisangani, 2.9% (3/102) in Boende, and 0.9% (1/112) in Basankusu. These results suggest high resistance to pyrimethamine alone or combined with sulfadoxine. Adding artesunate to SP does not seem a valid alternative to the current monotherapy.

Received October 3, 2005. Accepted for publication February 9, 2006.

Acknowledgments: The authors thank Dr. Nsibu Ndosimao, General Director of the PNLP, for authorizing this study, Dr. Alphonse Swana-Nimy for representing PNLP on the field, and Dr. Kristina Persson and Dr. Anja Huefner who supervised the data collection on the field. We also thank Rebecca Freeman Grais at Epicentre headquarters for reviewing an earlier draft of the manuscript.

Financial support: This study was funded by Médecins sans Frontières. The American Society of Tropical Medicine and Hygiene (ASTMH) assisted with publication expenses.

* Address correspondence to Jean-Paul Guthmann, Epicentre, 8 rue Saint Sabin, 75011 Paris, France. E-mail: jguthmann{at}epicentre.msf.org

Authors’ addresses: Sandra Cohuet, Maryline Bonnet, and Jean-Paul Guthmann, Epicentre, 8 rue Saint Sabin, 75011 Paris, France. E-mails: sandra.cohuet{at}lshtm.ac.uk, maryline.bonnet{at}geneva.msf.org, and jguthmann{at}epicentre.msf.org; Michel van Herp, Médecins sans Frontières, 94 rue Dupré, 1090 Brussels, Belgium, E-mail: michel.vanherp{at}msf.be; Chantal van Overmeir and Umberto D’Alessandro, Prince Léopold Institute of Tropical Medicine, 155 Nationalestraat, B-2000 Antwerp, Belgium, E-mails: cvoverm{at}itg.be and udalessandro{at}itg.be.

Reprints requests: Jean-Paul Guthmann, Epicentre, 8 rue Saint Sabin, 75011 Paris, France. E-mail: jguthmann{at}epicentre.msf.org.




This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
S. Rulisa, J. P. Gatarayiha, T. Kabarisa, and G. Ndayisaba
Comparison of Different Artemisinin-based Combinations for the Treatment of Plasmodium falciparum Malaria in Children in Kigali, Rwanda, an Area of Resistance to Sulfadoxine-Pyrimethamine: Artesunate Plus Sulfadoxine/Pyrimethamine versus Artesunate Plus Sulfamethoxypyrazine/Pyrimethamine
Am J Trop Med Hyg, October 1, 2007; 77(4): 612 - 616.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society of Tropical Medicine and Hygiene.